CRX.L Regulatory News (CRX)

1 Jun 2005 11:54

Cyprotex PLC01 June 2005 Press Release 1 June 2005 Cyprotex Plc ("Cyprotex" or "the Company") AGM Statement Cyprotex (LSE: CRX) announces that, at the Annual General Meeting held onWednesday 1 June 2005, all the resolutions proposed were duly passed and thefinancial statements were approved. Robert Morrisson Atwater, Chairman and CEO of Cyprotex Plc, said: "I would liketo express my satisfaction with regards to the reorganisation of the Company in2004. 2005 has started in line with management's best expectations. "In addition, we are at an advanced stage of negotiations on a significant newcontract with a major US biopharmaceutical group. This new deal would be inline with our aim to develop further, both geographically and by contract size." - Ends - For further information: Cyprotex PLCRobert Morrisson Atwater, Tel: +44 (0) 1625 505 152Chairman & Chief Executive Officerir@cyprotex.com www.cyprotex.com Code SecuritiesCharles Walker Tel: +44 (0) 20 7024 2000cew@codesecurities.com www.codesecurities.com Media enquiries:Abchurch CommunicationsHeather Salmond / Margaret Strinati Tel: +44 (0) 20 7398 7700heather.salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange